Delivery Order VA69D17D0150-VA69D17J3649

This is a Blanket Purchase Agreement (BPA) call contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 21 (VISN 21) to Pacific Compounding Pharmacy And Consultations, Inc., a for-profit corporate entity that manufactures customized pharmaceutical products and provides consultations as a specialty compounding pharmacy. The contract, valued at $312,920.00, is for the provision of pharmaceutical compounding services. This...

This is a firm fixed price contract awarded by the Defense Health Agency, a component of the Department of Defense, to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business, to provide specialized pharmaceutical compounds and medications to address shortages impacting patient care at military and civilian treatment facilities. The $650,000 contract is a blanket purchase agreement (BPA) call that allows for the expedited acquisition of customized drugs and...

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $6,767.54, is for the delivery of FYCOMPA 0.5 MG/ML oral suspension in 340 mL bottles. This is a firm-fixed price delivery order contract with a completion date of November 27, 2023. The contract is not associated with a set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...

This is a firm fixed price BPA call order awarded by the Defense Health Agency to Pharmakon Pharmaceutical, Inc., a woman-owned small business, for the provision of sterile compounds for the Walter Reed National Military Medical Center (WRNMMC). The total ceiling value of the contract is $983,313.32, with a period of performance through September 30, 2016. This contract does not have a set-aside designation. No further details about potential subcontractors or the agency's broader programs are...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $50,000 firm fixed price delivery order contract to Central Admixture Pharmacy Services, Inc. of Irvine, California. The contract is for 503 B compounded products as needed from Central Admixture Pharmacy Services, Inc.'s central admixture pharmacy under solicitation number 20-000048. No set aside designation was used for this award. Performance will occur at the awardee's listed place of...

This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Fycompa 0.5 mg/ml oral suspension in 340 ml containers. The contract has a ceiling value of $7,287.00 and a period of performance through February 4, 2025. It is a firm-fixed-price contract type. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds several large...

This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Central Admixture Pharmacy Services, Inc. (doing business as Caps), a for-profit organization specializing in compounded sterile pharmaceutical preparations. The contract, valued at $250,000.00, is for CAPS COMPOUNDED PRESENTATIONS and does not have a set-aside designation. Central Admixture Pharmacy Services, Inc. has multiple Indefinite Delivery Vehicles (IDVs) with federal...

This is a $46,275.84 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Independent Pharmacy Cooperative, a small business concern. The contract is for the delivery of various pharmaceutical products, including PEG-400/Propylene Glycol solution, Sevelamer Carbonate tablets, Fenofibrate tablets, and Febuxostat tablets, to the VA's Central Medical Oxygen and Pharmaceuticals (CMOP) facility in Hines, Illinois. The contract has a completion date of April 28,...

This is a firm fixed price contract awarded by the Defense Health Agency (DHA) to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business. The $300,000 contract provides the DHA with a variety of pharmaceutical products, including blood products, oncology drugs, and other injectable, oral, and inhalation medications to address shortages impacting patient care at military and civilian treatment facilities. The contract is structured as a Blanket Purchase...

The Defense Health Agency awarded a firm fixed price blanket purchase agreement (BPA) call to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business, to provide prescription pharmaceuticals such as vinblastine, carimune, and oncological medications. The $250,000 contract has no set-aside designation and supports the urgent needs of military treatment facilities, including Walter Reed National Military Medical Center, by delivering specialized, customized...